Evidence map›Paper›PMID 36920164›Full record

ArticleBiopharmaceutical report2022

RWD-INTEGRATED RANDOMIZED CLINICAL TRIAL ANALYSIS.

Shu Yang, Xiaofei Wang

Abstract read
In one paragraph

Article in Biopharmaceutical report, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. COADVISE: covariate adjustment with variable selection in randomized controlled trials.Journal of the Royal Statistical Society. Series A, (Statistics in Society) · 2026
    Article
  2. Data fusion methods for the heterogeneity of treatment effect and confounding function.Bernoulli : official journal of the Bernoulli Society for Mathematical Statistics and Probability · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Causal Inference Methods for Combining Randomized Trials and Observational Studies: A Review.Statistical science : a review journal of the Institute of Mathematical Statistics · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Shu YangNorth Carolina State University.
Xiaofei WangDuke University.

Funding

Transforming Clinical Trials for Elderly and Rare Cancers through Intelligent and Robust Information BorrowingR01AG066883 · NIA · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI Xiaofei Wang, Shu Yang · 2020 to 2026
$2.0M
FDA HHS U01 FD007934NIA NIH HHS R01 AG066883
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36920164
PMCPMC10009505

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.